Insomnia Trends and Forecast
The future of the global insomnia market looks promising with opportunities in the capsule and tablet markets. The global insomnia market is expected to reach an estimated $5.1 billion by 2030 with a CAGR of 3.6% from 2024 to 2030. The major drivers for this market are growing prevalence of different types of sleep disorders like insomnia and parasomnias, expanding insurance coverage for insomnia treatments, and increasing government initiatives to support sleep insomnia treatment.
• Lucintel forecasts that, within the type of therapy category, non-pharmacological therapy will remain a larger segment over the forecast period due to advances in nonpharmacologic sleep therapy along with the launch of new products.
• Within the drug formulation category, capsule is expected to witness the highest growth due to high number of product approvals and product development activities.
• In terms of regions, North America will remain the largest region over the forecast period due to growing incidence of sleep disorders increased awareness and rising healthcare spending in the region.
A more than 150-page report is developed to help in your business decisions.
Emerging Trends in the Insomnia Market
The insomnia market is evolving with several emerging trends that are shaping its future.
• Digital Health and Telemedicine: The adoption of digital health solutions and telemedicine is a significant trend in the insomnia market. Mobile apps offering CBT-I and sleep tracking are becoming increasingly popular, providing patients with accessible and personalized treatment options. Telemedicine services are also enabling remote consultations with sleep specialists, broadening access to care.
• Personalized Medicine: The move toward personalized medicine is gaining momentum in the insomnia market. New treatments are being developed to address specific types of insomnia, such as sleep-onset or maintenance insomnia. This trend is leading to more effective and targeted therapies that cater to the unique needs of each patient.
• Non-Pharmacological Interventions: There is growing interest in non-pharmacological interventions for managing insomnia. These include mindfulness meditation, relaxation techniques, and lifestyle modifications that promote better sleep hygiene. This trend is driven by concerns over the side effects of long-term medication use and the desire for holistic treatment approaches.
• Natural and Herbal Remedies: The demand for natural and herbal remedies is rising as consumers seek alternatives to prescription medications. Products containing melatonin, valerian root, and other natural ingredients are gaining popularity as safe and effective options for improving sleep quality.
• Smart Sleep Technology: Innovations in smart sleep technology are transforming the insomnia market. Wearable sleep trackers, smart mattresses, and sleep-focused home devices are becoming mainstream, offering real-time monitoring and data-driven insights to help users optimize their sleep patterns.
• Focus on Mental Health: The link between mental health and sleep disorders is increasingly recognized, leading to an integrated approach to treating insomnia. Mental health platforms and apps that address anxiety, stress, and depression alongside sleep issues are emerging as key tools in the management of insomnia.
The insomnia market is being shaped by emerging trends such as digital health, personalized medicine, and non-pharmacological interventions, which are driving innovation and improving patient outcomes.
Recent Developments in the Insomnia Market
The insomnia market has seen several significant developments in recent years, driving its growth and innovation.
• Approval of New Medications: Recent developments in the insomnia market include the approval of novel medications, such as dual orexin receptor antagonists (DORAs), which offer a new mechanism of action for treating insomnia. These drugs are gaining traction due to their efficacy and lower risk of dependence compared to traditional sleep medications.
• Growth in Digital Therapeutics: The market is witnessing a surge in digital therapeutics, particularly mobile apps and online platforms that provide CBT-I. These tools are becoming increasingly popular as they offer non-pharmacological options for managing insomnia and are easily accessible to a wide range of patients.
• Expansion of Telemedicine: The expansion of telemedicine services is another key development in the insomnia market. With the rise of remote consultations, patients now have easier access to sleep specialists and personalized treatment plans, which is particularly beneficial in underserved areas.
• Advances in Sleep Technology: The insomnia market is benefiting from advances in sleep technology, including the development of smart mattresses, sleep trackers, and wearable devices that monitor sleep patterns and provide data-driven insights for improving sleep quality.
• Increased Focus on Mental Health: There is an increasing focus on the connection between mental health and insomnia, leading to the development of integrated treatment approaches. Recent developments include the introduction of mental health apps that address anxiety and stress alongside sleep disorders.
• Investment in Research: The insomnia market is seeing increased investment in research and development, with ongoing studies exploring new pharmacological treatments, non-pharmacological interventions, and the underlying causes of sleep disorders. This research is driving the discovery of innovative solutions for managing insomnia.
Recent developments in the insomnia market, such as the approval of new medications and the growth of digital therapeutics, are driving innovation and expanding treatment options for patients.
Strategic Growth Opportunities for Insomnia Market
The insomnia market offers several strategic growth opportunities, particularly in key application areas.
• Home Care and Self-Management: The home care segment presents significant growth opportunities as more individuals seek to manage their insomnia independently. Products such as over-the-counter sleep aids, sleep trackers, and CBT-I apps are in high demand, offering convenient and accessible treatment options for home use.
• Healthcare and Telemedicine Services: Telemedicine services are a growing application area for the insomnia market, providing remote consultations and personalized care plans. This segment is particularly promising in regions with limited access to sleep specialists, enabling more patients to receive expert care.
• Pharmaceuticals and Prescription Medications: The pharmaceutical segment continues to offer growth opportunities, particularly with the development of new medications such as DORAs and other novel sleep agents. Companies that invest in research and development of these drugs can capture a significant share of the insomnia market.
• Sleep Clinics and Specialized Centers: Sleep clinics and specialized centers represent a key application area for the insomnia market. These facilities are increasingly adopting advanced diagnostic tools and personalized treatment plans, driving growth in the clinical segment of the market.
• Mental Health Integration: The integration of mental health and sleep disorder treatments is an emerging application area with substantial growth potential. Platforms that offer combined care for insomnia, anxiety, and depression are gaining traction, addressing the interconnected nature of these conditions.
• Natural and Herbal Products: The market for natural and herbal products is expanding as consumers seek safer alternatives to traditional medications. Companies that focus on developing and marketing effective natural remedies, such as melatonin and valerian root, can tap into this growing demand.
The insomnia market offers strategic growth opportunities in key application areas such as home care, telemedicine, and pharmaceuticals, driven by the increasing demand for effective and accessible treatment options.
Insomnia Market Driver and Challenges
The insomnia market is driven by several key factors, but it also faces challenges that impact its growth.
The factors responsible for driving the insomnia market include:
• Increasing Prevalence of Sleep Disorders: The rising prevalence of sleep disorders, including insomnia, is a primary driver of the market. Factors such as stress, anxiety, and lifestyle changes are contributing to an increase in sleep-related issues, leading to higher demand for insomnia treatments.
• Growing Awareness of Sleep Health: There is growing awareness of the importance of sleep health and its impact on overall well-being. This awareness is driving individuals to seek treatment for insomnia, contributing to market growth.
• Advancements in Treatment Options: Continuous advancements in treatment options, including new medications, digital therapeutics, and non-pharmacological interventions, are driving the growth of the insomnia market. These innovations are providing patients with more effective and personalized care.
• Expansion of Digital Health Solutions: The expansion of digital health solutions, such as mobile apps and telemedicine services, is making insomnia treatments more accessible to a broader population. These solutions are particularly popular among tech-savvy consumers seeking convenient and cost-effective options.
• Increased Focus on Mental Health: The growing focus on mental health and its connection to sleep disorders is driving demand for integrated treatment approaches. This trend is leading to the development of comprehensive care plans that address both insomnia and underlying mental health issues.
Challenges in the insomnia market are:
• High Cost of Treatment: The high cost of advanced insomnia treatments, particularly prescription medications and specialized care, is a significant challenge. This cost barrier limits access to effective treatments, particularly in lower-income populations.
• Side Effects of Medications: The side effects associated with some insomnia medications, such as dependency and cognitive impairment, pose challenges to their widespread adoption. Patients and healthcare providers are increasingly cautious about the long-term use of these drugs.
• Limited Access to Sleep Specialists: Access to sleep specialists is limited in certain regions, particularly in rural and underserved areas. This challenge is compounded by a shortage of trained professionals, which can delay diagnosis and treatment.
• Regulatory Hurdles: The insomnia market faces regulatory challenges, particularly in the approval and distribution of new treatments. Stringent regulations and varying approval processes across regions can lead to delays in product launches and increased costs.
• Stigma and Misconceptions: Stigma and misconceptions about sleep disorders can prevent individuals from seeking treatment. This challenge is particularly prevalent in cultures where sleep issues are not widely recognized as medical conditions.
• Competition from Alternative Therapies: The insomnia market faces competition from alternative therapies, such as herbal remedies and lifestyle changes. These alternatives are often perceived as safer and more natural, which can impact the demand for conventional treatments.
The insomnia market is driven by factors such as the increasing prevalence of sleep disorders and advancements in treatment options, but it also faces challenges related to high treatment costs, side effects, and regulatory hurdles.
List of Insomnia Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies insomnia companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the insomnia companies profiled in this report include-
• Vanda Pharmaceuticals
• Neurim
• Eisai
• Purdue Pharma
• Merck
• Pfizer
• Astellas
• Flynn Pharma
• Takeda Pharmaceutical
• SkyePharma
Insomnia by Segment
The study includes a forecast for the global insomnia by type of therapy, drug formulation, type of disease, and region.
Insomnia Market by Type of Therapy [Analysis by Value from 2018 to 2030]:
• Pharmacological Therapy
• Non-Pharmacological Therapy
Insomnia Market by Drug Formulation [Analysis by Value from 2018 to 2030]:
• Capsules
• Tablets
• Others
Insomnia Market by Type of Disease [Analysis by Value from 2018 to 2030]:
• Poor Quality of Sleep
• Sleep Maintenance
• Others
Insomnia Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
Country Wise Outlook for the Insomnia Market
Major players in the market are expanding their operations and forming strategic partnerships to strengthen their positions. The image below highlights recent developments by major insomnia market producers in key regions: the USA, China, India, Germany, and Japan.
• United States: The insomnia market in the United States is witnessing significant advancements, driven by the high prevalence of sleep disorders among the population. Recent developments include the FDA approval of novel medications, such as dual orexin receptor antagonists (DORAs), which offer a new mechanism of action for treating insomnia. Additionally, there is an increasing adoption of digital therapeutics, such as mobile applications and online cognitive behavioral therapy (CBT-I) programs, designed to help patients manage insomnia without medication. The U.S. market is also seeing growth in the development of non-pharmacological solutions, including wearable sleep trackers and smart mattresses that monitor and improve sleep quality.
• United Kingdom: In the UK, the insomnia market is expanding due to growing awareness of sleep health and its impact on overall well-being. The National Health Service (NHS) has been promoting digital interventions, such as Sleepio, a CBT-I app that has gained popularity for its effectiveness in treating insomnia. The UK is also seeing increased research into the use of melatonin and other over-the-counter sleep aids, reflecting a shift toward non-prescription treatments. Furthermore, the market is being shaped by innovations in sleep technology, with companies introducing smart home devices and sleep-focused wearables that aim to improve sleep hygiene and monitor sleep patterns.
• China: ChinaÄX%$%Xs insomnia market is growing rapidly, driven by increasing stress levels and urbanization that contribute to sleep disorders among the population. Recent developments include the launch of new herbal-based sleep aids that cater to the preference for traditional medicine in China. Additionally, there is a rising demand for mobile health (mHealth) apps that offer sleep tracking and relaxation techniques, reflecting the tech-savvy nature of Chinese consumers. The market is also witnessing the entry of international pharmaceutical companies, which are introducing prescription medications and innovative sleep solutions tailored to the Chinese market.
• Australia: AustraliaÄX%$%Xs insomnia market is experiencing growth due to the rising prevalence of sleep disorders and increased awareness of mental health issues. Recent developments include the introduction of digital health platforms that provide CBT-I and mindfulness programs to help individuals manage insomnia. Australian researchers are also focusing on the development of novel pharmacological treatments, with ongoing clinical trials exploring the efficacy of various compounds in improving sleep quality. Additionally, the Australian market is seeing the expansion of sleep clinics and specialized sleep centers that offer comprehensive diagnostics and personalized treatment plans for insomnia patients.
• Germany: In Germany, the insomnia market is evolving with a focus on personalized medicine and integrated care approaches. Recent developments include the introduction of prescription medications that offer targeted treatments for different types of insomnia, such as sleep-onset or maintenance insomnia. The German market is also embracing digital health innovations, with the rise of telemedicine services that provide remote consultations and CBT-I programs. Additionally, Germany is investing in research to better understand the underlying causes of insomnia, leading to the development of new therapeutic options and preventative measures. There is also a growing market for natural sleep aids, including herbal supplements and homeopathic remedies.
Features of the Global Insomnia Market
Market Size Estimates: Insomnia market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Insomnia market size by type of therapy, drug formulation, type of disease, and region in terms of value ($B).
Regional Analysis: Insomnia market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different type of therapy, drug formulations, type of disease, and regions for the insomnia market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the insomnia market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.
FAQ
Q1. What is the insomnia market size?
Answer: The global insomnia market is expected to reach an estimated $5.1 billion by 2030.
Q2. What is the growth forecast for insomnia market?
Answer: The global insomnia market is expected to grow with a CAGR of 3.6% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the insomnia market?
Answer: The major drivers for this market are growing prevalence of different types of sleep disorders like insomnia and parasomnias, expanding insurance coverage for insomnia treatments, and increasing government initiatives to support sleep insomnia treatment.
Q4. What are the major segments for insomnia market?
Answer: The future of the insomnia market looks promising with opportunities in the capsule and tablet markets.
Q5. Who are the key insomnia market companies?
Answer: Some of the key insomnia companies are as follows:
• Vanda Pharmaceuticals
• Neurim
• Eisai
• Purdue Pharma
• Merck
• Pfizer
• Astellas
• Flynn Pharma
• Takeda Pharmaceutical
• SkyePharma
Q6. Which insomnia market segment will be the largest in future?
Answer: Lucintel forecasts that non-pharmacological therapy will remain the larger segment over the forecast period due to advances in nonpharmacologic sleep therapy along with the launch of new products.
Q7. In insomnia market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to growing incidence of sleep disorders increased awareness and rising healthcare spending in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the insomnia market by type of therapy (pharmacological therapy and non-pharmacological therapy), drug formulation (capsules, tablets, and others), type of disease (poor quality of sleep, sleep maintenance, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Insomnia Market, Insomnia Market Size, Insomnia Market Growth, Insomnia Market Analysis, Insomnia Market Report, Insomnia Market Share, Insomnia Market Trends, Insomnia Market Forecast, Insomnia Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.